This page is historical material reflecting the Feedback Loop Blog as it existed on May 7, 2013. This page is no longer updated and links to external websites and some internal pages may not work.
May 7, 2013

Archived: Fiscal Year 2012 R01 Funding Outcomes

By Judith Greenberg
Fiscal Year 2012 ended on September 30, 2012. As in previous years, we have analyzed the funding results (including percentiles and success rates) for R01 grants, shown in Figures 1-5. Thanks to Jim Deatherage for preparing these data again this year.
Figure 1. Competing R01 applications reviewed (open rectangles) and funded (solid bars) in Fiscal Year 2012. View larger image
Figure 1. Competing R01 applications reviewed (open rectangles) and funded (solid bars) in Fiscal Year 2012.
Figure 2. NIGMS competing R01 funding curves for Fiscal Years 2008-2012. For Fiscal Year 2012, the success rate for R01 applications was 25%, and the midpoint of the funding curve was at approximately the 20th percentile. View larger image
Figure 2. NIGMS competing R01 funding curves for Fiscal Years 2008-2012. For Fiscal Year 2012, the success rate for R01 applications was 25%, and the midpoint of the funding curve was at approximately the 20th percentile.
In Fiscal Year 2012, there was a slight improvement in success rate. This is due in part to the relatively flat number of competing applications that we received (Figure 4).
Figure 3. Number of R01 and R37 grants (competing and noncompeting) funded in Fiscal Years 1998-2012. View larger image
Figure 3. Number of R01 and R37 grants (competing and noncompeting) funded in Fiscal Years 1998-2012.
Figure 4. Number of competing R01 applications (including resubmissions) received during Fiscal Years 1998-2012. View larger image
Figure 4. Number of competing R01 applications (including resubmissions) received during Fiscal Years 1998-2012.
Below are the total NIGMS expenditures (including both direct and indirect costs) for R01 and R37 grants for Fiscal Year 1996 through Fiscal Year 2012.
Figure 5. The upper curve shows the overall NIGMS expenditures on R01 and R37 grants (competing and noncompeting, including supplements) in Fiscal Years 1996-2012. The lower curve (right vertical axis) shows the median direct costs of NIGMS R01 grants. Results are in actual dollars with no correction for inflation. View larger image
Figure 5. The upper curve shows the overall NIGMS expenditures on R01 and R37 grants (competing and noncompeting, including supplements) in Fiscal Years 1996-2012. The lower curve (right vertical axis) shows the median direct costs of NIGMS R01 grants. Results are in actual dollars with no correction for inflation.
topic Budget , Director’s Messages , Funding Trends

About the Author

Judith Greenberg

Judith Greenberg

Before her retirement in October 2020, Judith was the deputy director of NIGMS and the acting director of the Division of Biophysics, Biomedical Technology, and Computational Biosciences. In the past, she also served as the acting director of the Institute and as the director of the former Division of Genetics and Developmental Biology. She led the development of the NIGMS strategic plan issued in 2008 and the development and implementation of the NIGMS strategic plan for training issued in 2011.